Lv1
50 积分 2025-07-02 加入
The Mas agonist CGEN-856S prevents Ang II induced cardiomyocyte hypertrophy via nitric oxide production
2天前
已完结
Therapeutic Targeting of the Tumor Microenvironment
1个月前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
1个月前
已完结
Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy
1个月前
已完结
皖公网安备34019202002308
